Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2025 16:05 ET | Source: electroCore, Inc.

electroCore Announces Second Quarter 2025 Financial Results

Net sales of $7.4 million increased 20% vs. Q2’2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024 Cash, cash equivalents, restricted cash, and marketable securities of $7.4...
July 23, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

ROCKAWAY, N.J., July 23, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial...
July 22, 2025 16:05 ET | Source: electroCore, Inc.

electroCore to Participate in Upcoming Investor Conferences

ROCKAWAY, N.J., July 22, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
April 03, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times

ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recognized by the Financial Times as one...
March 31, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Extends VA Contract for Five Years

ROCKAWAY, N.J., March 31, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that electroCore has received a...
February 04, 2025 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its participation in the 12th...
December 17, 2024 16:05 ET | Source: electroCore, Inc.

electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and Wellness

The Quell® platform will strengthen our position as a significant player in the bioelectronic health and wellness sector Company to discuss acquisition and host investor Q&A in a webcast today at...
November 14, 2024 08:00 ET | Source: electroCore, Inc.

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21

ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate...
October 23, 2024 08:00 ET | Source: electroCore, Inc.

electroCore to Announce Third Quarter September 30, 2024 Financial Results on Wednesday, November 13, 2024

ROCKAWAY, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that it will report financial...
September 24, 2024 08:00 ET | Source: electroCore, Inc.

electroCore Engages FNK IR to Execute Expanded Investor Relations Program

ROCKAWAY, N.J., Sept. 24, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has engaged FNK IR, an...